ID

25172

Beskrivning

Tysabri Observational Program; ODM derived from: https://clinicaltrials.gov/show/NCT00493298

Länk

https://clinicaltrials.gov/show/NCT00493298

Nyckelord

Versioner (1)
  1. 2017-08-28 2017-08-28 -
Uppladdad den

28 augusti 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

Engelsk

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

1 Formulär  
Criteria
Beskrivning

Criteria

documented diagnosis of relapsing remitting multiple sclerosis
Beskrivning

Multiple Sclerosis, Relapsing-Remitting

Datatyp

boolean

Alias
UMLS CUI [1]
C0751967
the decision to treat with tysabri must precede enrollment
Beskrivning

Tysabri

Datatyp

boolean

Alias
UMLS CUI [1]
C1529600
patient must be a new tysabri user, and must not have had more than 3 tysabri infusions prior to enrollment
Beskrivning

Tysabri Use of Firstly | Tysabri Infusion Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1529600
UMLS CUI [1,2]
C1524063
UMLS CUI [1,3]
C1279901
UMLS CUI [2,1]
C1529600
UMLS CUI [2,2]
C0574032
UMLS CUI [2,3]
C1265611
must have had at least one relapse in the previous year, and must satisfy locally approved therapeutic indications for tysabri
Beskrivning

Relapse Quantity | Indication Tysabri

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C1529600
key exclusion criteria:
Beskrivning

Exclusion Criteria Main

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
history of progressive multifocal leukoencephalopathy or other opportunistic infections, or an increased risk of opportunistic infections
Beskrivning

Leukoencephalopathy, Progressive Multifocal | Opportunistic Infections | Opportunistic Infections Risk Increased

Datatyp

boolean

Alias
UMLS CUI [1]
C0023524
UMLS CUI [2]
C0029118
UMLS CUI [3,1]
C0029118
UMLS CUI [3,2]
C0035647
UMLS CUI [3,3]
C0205217
history of positive anti-natalizumab antibodies
Beskrivning

Natalizumab Ab Positive

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1977362
UMLS CUI [1,2]
C1514241
concomitant immunomodulatory or immunosuppressive therapy during therapy with tysabri
Beskrivning

Immunomodulation | Therapeutic immunosuppression | Tysabri

Datatyp

boolean

Alias
UMLS CUI [1]
C1963758
UMLS CUI [2]
C0021079
UMLS CUI [3]
C1529600
patient immunocompromised at the time of enrollment
Beskrivning

Patient Immunocompromised

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0085393
known active malignancy
Beskrivning

Malignant Neoplasms

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
women must not be breast feeding or pregnant, or planning to become pregnant (must use birth control unless surgically sterile)
Beskrivning

Breast Feeding | Pregnancy | Pregnancy, Planned | Gender Contraceptive methods | Exception Female Sterilization

Datatyp

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0700589
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0015787
note: other protocol defined inclusion/exclusion criteria may apply.
Beskrivning

Clinical Trial Eligibility Criteria Study Protocol

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Tillbaka till toppen

Similar models

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Multiple Sclerosis, Relapsing-Remitting
Item
documented diagnosis of relapsing remitting multiple sclerosis
boolean
C0751967 (UMLS CUI [1])
Tysabri
Item
the decision to treat with tysabri must precede enrollment
boolean
C1529600 (UMLS CUI [1])
Tysabri Use of Firstly | Tysabri Infusion Quantity
Item
patient must be a new tysabri user, and must not have had more than 3 tysabri infusions prior to enrollment
boolean
C1529600 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C1279901 (UMLS CUI [1,3])
C1529600 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Relapse Quantity | Indication Tysabri
Item
must have had at least one relapse in the previous year, and must satisfy locally approved therapeutic indications for tysabri
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1529600 (UMLS CUI [2,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Leukoencephalopathy, Progressive Multifocal | Opportunistic Infections | Opportunistic Infections Risk Increased
Item
history of progressive multifocal leukoencephalopathy or other opportunistic infections, or an increased risk of opportunistic infections
boolean
C0023524 (UMLS CUI [1])
C0029118 (UMLS CUI [2])
C0029118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205217 (UMLS CUI [3,3])
Natalizumab Ab Positive
Item
history of positive anti-natalizumab antibodies
boolean
C1977362 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
Immunomodulation | Therapeutic immunosuppression | Tysabri
Item
concomitant immunomodulatory or immunosuppressive therapy during therapy with tysabri
boolean
C1963758 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C1529600 (UMLS CUI [3])
Patient Immunocompromised
Item
patient immunocompromised at the time of enrollment
boolean
C0030705 (UMLS CUI [1,1])
C0085393 (UMLS CUI [1,2])
Malignant Neoplasms
Item
known active malignancy
boolean
C0006826 (UMLS CUI [1])
Breast Feeding | Pregnancy | Pregnancy, Planned | Gender Contraceptive methods | Exception Female Sterilization
Item
women must not be breast feeding or pregnant, or planning to become pregnant (must use birth control unless surgically sterile)
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0015787 (UMLS CUI [5,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
note: other protocol defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial